‘Blatant daylight dacoity’: SC questions 10-fold price gap in cancer drug, asks authorities why they failed to act
viaHindustan Times23 Sept

The court raised concerns over the burden on patients after hearing that a cancer medicine bought by retailers for ₹2,700 reaches consumers at ₹27,000.
Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to Hindustan Times's own reporting rather than reproducing it — the excerpt above comes from Hindustan Times's own feed.
Read the full story on Hindustan Times ↗